The cross-disciplinary focus of the meeting highlighted recent progress in physical and genetic analysis and engineering of cancer disease models. As central theme, mechanical forces affecting cell signaling, growth, differentiation and metastasis were discussed with emphasis on the tumor microenvironment and cellular immunity, taking into account novel nanotechnology, biosensing and intravital microscopy tools to monitor animal cancer models and human cancer.
Rakesh K. Jain (Massachusetts General Hospital, Boston, MA) gave the keynote address on normalization of tumor microenvironment to treat cancer as demonstrated by mathematical model and experimentation in mouse and in humans. Blood and lymphatic vessels and matrix associated with tumors are abnormal; these abnormalities can fuel tumor progression and prevent drugs from reaching tumor cells. In vivo imaging of tumors allowed the study of the effects of microenvironment (ME) on tumor cells and vice versa. Relaxin decreases collagen production and increases responses. Angiogenic drugs can also "normalize" tumor ME.
More recently, anti-hypertensive drugs were shown to "normalize" the collagen matrix and improve the delivery and efficacy of therapeutics. Author Manuscript Published OnlineFirst on January 11, 2012; DOI: 10.1158/0008-5472.CAN-11-3080 other with respect to cell adhesion response which was displayed in a phase diagram for adhesion.
David Weitz (Harvard University School of Engineering and Applied Sciences, Cambridge, MA) discussed the relationships between cell volume and stiffness and the role of ECM. Cell stiffness and shape depend on substrate stiffness. The size of the nucleus also changes with changes in cell size as does the motion of particles within cells. Cells exert forces through ECM which affect motion and deformation.
Dennis Discher (University of Pennsylvania, Philadelphia, PA) discussed the effects of matrix stiffness on migration and differentiation. Crosslinked tissue matrices were imitated in their elasticity with polymeric hydrogels, demonstrating the potent influence of matrix elasticity on basic processes such as stem cell differentiation. Nuclear structure-function and conformational flexibility were focused upon with novel mass spectromatic proteomic approaches, and the plasticity of the nucleus in stem cell differentiation was highlighted. In parallel studies with a more therapeutic focus on flexibility, Worm-like polymer micelles that easily deform were shown to better deliver anti-cancer agents such as taxol compared to nanospherical shapes. The interplay between materials biophysics and biomolecular engineering was thus illustrated with diverse examples.
Paul Janmey (University of Pennsylvania, Philadelphia, PA) indicated that cell proliferation, morphology, motility, and protein expression are modulated in response to substrate stiffness. This can vary and reflects the elastic modulus of the tissue from which these cells were isolated. The viscoelastic properties of different ECM and cytoskeletal elements influence the cell responses to mechanical signals; non-linear elasticity of biopolymer gels leads to novel mechanisms by which cells alter their stiffness through engaging molecular motors producing internal stresses. Hepatic stellate cells convert into a spread phenotype, depending January 11, 2012; DOI: 10.1158/0008-5472.CAN-11-3080 upon the stiffness of ECM. The simultaneous control of substrate stiffness and adhesive patterns suggests that stiffness sensing occurs on a scale much larger than single molecular linkages and that the time needed for mechanosensing is on the order of a few seconds. 2012; DOI: 10.1158/0008-5472.CAN-11-3080 Melody Swartz (Ecole Polytechnique Federale and PDGF) and mesenchymal stem cell migration and osteogenesis (in response to BMP-2 and PDGF): synergy was seen only when the growth factors were templated by a fusion protein of the two domains appropriately spaced. Polymeric nanomaterials were developed that are rapidly cleared into lymphatics draining the injection site and paclitaxel was encapsulated. When injected intradermally into a tissue bed draining to the same lymph node as a tumor, tumor growth was inhibited and the number of tumor antigen-specific CD8+ T cells was elevated even though paclitaxel systemic doses were too low to demonstrate direct antitumor effects. 2012; DOI: 10.1158/0008-5472.CAN-11-3080 Mehmet Toner (Harvard Medical School, Cambridge, MA) introduced novel microfluid chips for the isolation of circulating tumors cells (CTCs) in metastatic cancer allowing to monitor patient response and changes in tumor genotypes during treatment. The CTC-Chip captured rare CTCs using antibody-coated micro-posts under laminar flow conditions. A chip based on high throughput microfluid mixing provided enhanced CTC isolation. In patients with metastatic cancer temporal changes in CTC numbers correlated well with disease clinical course. In patients with metastatic non-small-cell-lung cancer T790M mutation, which confers drug resistance was detected in CTCs from patients. CTCs were also isolated from blood of patients with metastatic or localized prostate cancer.
Tyler Jacks (Massachusetts Institute of Technology, Boston, MA) discussed the molecular analysis of lung cancer progression using a mouse model of the disease. These models share both genetic and pathological features of human non-small cell lung cancer. 
